FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1144-1152 April 27, 1995 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Hypoglycemia is a clinical syndrome with diverse causes in which low levels of plasma glucose eventually lead to neuroglycopenia. This review will be devoted to hypoglycemic disorders that do not result from the treatment of diabetes mellitus.

Glucose Counterregulation

In healthy persons, postabsorptive levels of plasma glucose stay within a narrow range (about 60 to 100 mg per deciliter [3.3 to 5.6 mmol per liter]) despite the intermittent ingestion of food. Insulin, the primary regulatory hormone that blunts postprandial hyperglycemia and maintains postabsorptive euglycemia, has its effects counterbalanced by several factors that provide a minimal level of glycemia in order to sustain . . . [Full Text of this Article]

Symptoms

Classification

Evaluation

The Healthy-Appearing Patient

Plasma Glucose Levels

            The 72-Hour Fast

            The C-Peptide Suppression and Intravenous Tolbutamide Tests

            Insulin Antibodies

            The Mixed-Meal Test

The Ill-Appearing Patient

Management

References

Related Letters:

Hypoglycemic Disorders
Piziak V.K., Cryar A. K., Rubin E., Service F. J.
Extract | Full Text  
N Engl J Med 1995; 333:1154-1155, Oct 26, 1995. Correspondence

This article has been cited by other articles:

• de Groot, J. W. B, Rikhof, B., van Doorn, J., Bilo, H. J G, Alleman, M. A, Honkoop, A. H, van der Graaf, W. T A (2007). Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer 14: 979-993 [Abstract] [Full Text]  
• Vella, A., Service, F. J. (2007). Incretin Hypersecretion in Post-Gastric Bypass Hypoglycemia Primary Problem or Red Herring?. J. Clin. Endocrinol. Metab. 92: 4563-4565 [Full Text]  
• Kann, P H, Ivan, D, Pfutzner, A, Forst, T., Langer, P, Schaefer, S (2007). Preoperative diagnosis of insulinoma: low body mass index, young age, and female gender are associated with negative imaging by endoscopic ultrasound. Eur J Endocrinol 157: 209-213 [Abstract] [Full Text]  
• Vezzosi, D, Bennet, A, Fauvel, J, Caron, P (2007). Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 157: 75-83 [Abstract] [Full Text]  
• Bryson, E. R., Snead, E. C.R., McMillan, C., MacDougall, L., Allen, A. L. (2007). Insulinoma in a Dog With Pre-existing Insulin-Dependent Diabetes Mellitus. Journal of the American Animal Hospital Association 43: 65-69 [Abstract] [Full Text]  
• Kar, P., Price, P., Sawers, S., Bhattacharya, S., Reznek, R. H., Grossman, A. B. (2006). Insulinomas May Present with Normoglycemia after Prolonged Fasting but Glucose-Stimulated Hypoglycemia. J. Clin. Endocrinol. Metab. 91: 4733-4736 [Abstract] [Full Text]  
• Kishore, P., Tonelli, J., Koppaka, S., Fratila, C., Bose, A., Lee, D.-E., Reddy, K., Hawkins, M. (2006). Time-Dependent Effects of Free Fatty Acids on Glucose Effectiveness in Type 2 Diabetes. Diabetes 55: 1761-1768 [Abstract] [Full Text]  
• Pistrosch, F., Bussemaker, E., Gross, P. (2006). An old patient with end stage renal disease and sudden onset of confusion and lethargy. Nephrol Dial Transplant 21: 813-815 [Full Text]  
• Service, F. J., O'Brien, P. C. (2005). Increasing Serum Betahydroxybutyrate Concentrations during the 72-Hour Fast: Evidence against Hyperinsulinemic Hypoglycemia. J. Clin. Endocrinol. Metab. 90: 4555-4558 [Abstract] [Full Text]  
• Vezzosi, D., Bennet, A., Rochaix, P., Courbon, F., Selves, J., Pradere, B., Buscail, L., Susini, C., Caron, P. (2005). Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol 152: 757-767 [Abstract] [Full Text]  
• Wiesli, P., Schwegler, B., Schmid, B., Spinas, G. A, Schmid, C. (2005). Mini-Mental State Examination is superior to plasma glucose concentrations in monitoring patients with suspected hypoglycaemic disorders during the 72-hour fast. Eur J Endocrinol 152: 605-610 [Abstract] [Full Text]  
• Kaltsas, G. A., Besser, G. M., Grossman, A. B. (2004). The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. Endocr. Rev. 25: 458-511 [Abstract] [Full Text]  
• Kagansky, N., Levy, S., Rimon, E., Cojocaru, L., Fridman, A., Ozer, Z., Knobler, H. (2003). Hypoglycemia as a Predictor of Mortality in Hospitalized Elderly Patients. Arch Intern Med 163: 1825-1829 [Abstract] [Full Text]  
• Chia, C. W., Saudek, C. D. (2003). The Diagnosis of Fasting Hypoglycemia Due to an Islet-Cell Tumor Obscured by a Highly Specific Insulin Assay. J. Clin. Endocrinol. Metab. 88: 1464-1467 [Abstract] [Full Text]  
• Bates, D. W. (2002). Unexpected Hypoglycemia in a Critically Ill Patient. ANN INTERN MED 137: 110-116 [Abstract] [Full Text]  
• (2001). An elderly man with pleural effusion and abnormal behaviour. Postgrad. Med. J. 77: 412a-412 [Full Text]  
• Furrer, J., Hättenschwiler, A., Komminoth, P., Pfammatter, T., Wiesli, P. (2001). Carcinoid Syndrome, Acromegaly, and Hypoglycemia Due to an Insulin-Secreting Neuroendocrine Tumor of the Liver. J. Clin. Endocrinol. Metab. 86: 2227-2230 [Abstract] [Full Text]  
• Hirshberg, B., Skarulis, M. C., Pucino, F., Csako, G., Brennan, R., Gorden, P. (2001). Repaglinide-Induced Factitious Hypoglycemia. J. Clin. Endocrinol. Metab. 86: 475-477 [Abstract] [Full Text]  
• Hojlund, K., Wildner-Christensen, M., Eshoj, O., Skjarbak, C., Holst, J. J., Koldkjar, O., Moller Jensen, D., Beck-Nielsen, H. (2001). Reference intervals for glucose, {beta}-cell polypeptides, and counterregulatory factors during prolonged fasting. Am. J. Physiol. Endocrinol. Metab. 280: E50-E58 [Abstract] [Full Text]  
• Service, F. J., Natt, N. (2000). The Prolonged Fast. J. Clin. Endocrinol. Metab. 85: 3973-3974 [Full Text]  
• Hirshberg, B., Livi, A., Bartlett, D. L., Libutti, S. K., Alexander, H. R., Doppman, J. L., Skarulis, M. C., Gorden, P. (2000). Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma. J. Clin. Endocrinol. Metab. 85: 3222-3226 [Abstract] [Full Text]  
• Empen, K., Otto, C., Muller-Hocker, J., Zapf, J., Schwandt, P. (2000). Case 1: Hypoglycemic Syncope Due to a Peripheral Neuroectodermal Tumor. JCO 18: 1594-1596 [Full Text]  
• Sapolsky, R. M., Romero, L. M., Munck, A. U. (2000). How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions. Endocr. Rev. 21: 55-89 [Abstract] [Full Text]  
• Laven, D. L., Oller, L. (2000). Drug Poisoning and Overdose for the Health Professional: Review of Select Over-the-Counter (OTC) and Prescription Medications. Journal of Pharmacy Practice 13: 37-81 [Abstract]  
• Le Roith, D. (1999). Tumor-Induced Hypoglycemia. NEJM 341: 757-758 [Full Text]  
• Scott, C. R., Frindik, J. P., Kemp, S. F., Kearns, G. L. (1996). Recurrent Hypoglycemia and Obesity in an Adolescent Insulinoma or Imitator?. CLIN PEDIATR 35: 157-160  
• Piziak, V.K., Cryar, A. K., Rubin, E., Service, F. J. (1995). Hypoglycemic Disorders. NEJM 333: 1154-1155 [Full Text]